Wunderink: Antipsychotics Can Be Tapered Safely Without Increasing Relapse Risk
Tapering antipsychotics slowly and with supported decision-making may improve care for patients with psychosis.
Antidepressants Not Superior to Psychotherapy for Severe Depression
On Wednesday, JAMA Psychiatry released a meta-analysis comparing the results of cognitive-behavioral therapy and antidepressant medication in severely depressed populations. Currently, many practice guidelines suggest that antidepressants be used over psychotherapy for major depressive disorder. The analysis, however, found that “patients with more severe depression were no more likely to require medications to improve than patients with less severe depression.”
Long-term Outcomes Better for Those Who Stop Taking Antipsychotics
Research undermines the prolonged use of antipsychotics in schizophrenia treatment, suggesting improved social functioning and quality of life with discontinuation.
Psychosocial Disability Rights and Digital Mental Health: An Interview with Piers Gooding
MIA's Emaline Friedman interviews legal scholar Piers Gooding on his work on disability rights and digital mental health technologies.
It is Time for Global Mental Health to Acknowledge Sociostructural Determinants of Distress
Researchers call for action to address social challenges and inequalities that obstruct mental health and well-being globally.
Ethical Issues Raised Over FDA Collaboration with Biogen on Failed Drug
The FDA collaborated with Biogen to conduct repeated re-analyses of aducanumab for Alzheimer's and FDA committee members are raising concerns.
Antiseizure Drug Exposure in Pregnancy Linked to Large Risk of Autism, ADHD, and Intellectual...
Harms are “largely overlooked by psychiatry despite widespread usage,” according to the researchers.
New Study Casts Doubt on Efficacy of Ketamine for Depression
A new study, published this month in the Journal of Affective Disorders, investigated the effectiveness of weekly intravenous ketamine injections as a treatment for...
Epilepsy Drugs Can Induce Psychosis in Some Patients, Study Finds
In this month’s issue of the journal Brain a new study investigates whether the drugs prescribed to control seizures can increase the risk of...
Researchers Set the Record Straight on Controversial Zoloft Study
An issue of Lancet Psychiatry is devoted to clarifying the lack of efficacy for Zoloft (sertraline).
Risk of Depression Spikes When Kids Take Ritalin
Risk of depression increased when children were taking methylphenidate for ADHD, but once they stopped taking the drug, depression risk dropped to normal levels.
Stimulant Prescribing Patterns for ADHD Not Impacted by Scientific Evidence
The article suggests that research challenging the evidence for ADHD drugs does not lead to changes without public campaigns.
Light Therapy Outperforms Prozac for Depression
In a new study, researchers found that bright light therapy was an effective treatment for nonseasonal major depressive disorder (MDD) while Prozac (Fluoxetine) alone...
New Data Reveal the Full Extent of STAR*D Failure
The initial study, which has been used to promote antidepressants, employed outcome switching to hide poor results.
Antidepressants Overprescribed to Post-Menopausal Women Despite Risks
A new study reveals that antidepressants, commonly prescribed to post-menopausal women, may increase risks of falls, cognitive decline, and cardiovascular issues, raising questions about their overuse in this population.
Identifying Psychiatric Drugs Leading to Emergency Room Visits
More than ten-percent of adults in the United States are currently prescribed at least one psychiatric medication but there is currently a lack of research on the prevalence of adverse drug events (ADEs) associated with these prescriptions outside of clinical trials.
Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan
MIA’s Ayurdhi Dhar interviews Ray Moynihan about the marketing of disorders, broadening of diagnoses, and harmful treatments.
When Psychology Speaks for You, Without You: Sunil Bhatia on Decolonizing Psychology
MIA’s Ayurdhi Dhar interviews Sunil Bhatia about decolonizing psychology, confronting the field’s racist past, colonial foundations, and neoliberal present.
Researchers Document Protracted Withdrawal from Antidepressants
Protracted Withdrawal Syndrome characterized by long-term adverse experiences after coming off of antidepressants.
Celia Brown, R.I.P.: Psychiatric Survivor, Pioneer, and Global Activist for Change
Celia Brown, a psychiatric survivor and activist who was revered — even beloved — for her foundational and ongoing efforts in mental health advocacy and the peer movement, has died after a battle with cancer.
Benzodiazepines Linked to Treatment Resistant Depression
Prior use of benzodiazepines, such as Xanax, Librium, or Ativan, may increase the risk of treatment-resistant depression (TRD), according to a new study published in The Journal of Nervous and Mental Disease.
New Study Examines Successful Discontinuation of Antipsychotics
A new study to be published in the next issue of Schizophrenia Research examines patients suffering from a first-episode of psychosis who stop taking any antipsychotic drugs. The researchers attempt to identify variables that can serve as predictors of the successful discontinuation of antipsychotics. They find, for example, that those who discontinue the drugs have, on average, the same outcomes as those who stay on them, and that those who have better social integration are more likely to discontinue without relapse.
Study Finds ADHD Drugs Alter Developing Brain
A new study, published in the JAMA Psychiatry, investigates the effect of stimulant ‘ADHD’ drugs on the brains of children and young adults. The...
Psychiatrists Argue For More Attention to Iatrogenic Harms
Psychiatrists argue that current practice fails to account for the interaction of biological, psychosocial and iatrogenic factors.
Withdrawal Symptoms Common for Those who Stop Taking Antidepressants
A new study, published in Molecular Psychiatry, investigates the prevalence and typical characteristics of antidepressant withdrawal syndrome (AWS) through analyzing available research. Researchers found...